Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194818 · ClinicalTrials.gov registry record · Phase 4
Asacol Dosing Study for Active Ulcerative Colitis
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT00194818: Completed Phase 4 study, sponsored by University of Washington.
NCT00194818 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194818, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
We, the investigators at University of Washington, plan on evaluating the effect of open label Asacol at a dose of 4.8 grams/day divided BID (twice per day) or TID (three times per day) on its ability to induce remission in patients with mild to moderately active ulcerative colitis. We hypothesize that both regimens will have the same efficacy and no difference in side effects.
Interventions
- DRUG Asacol (mesalamine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2003-06 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
What the finished NCT00194818 record still lists
NCT00194818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Asacol (mesalamine) is the first listed.
NCT00194818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00194818 about?
NCT00194818 is a clinical study titled "Asacol Dosing Study for Active Ulcerative Colitis". We, the investigators at University of Washington, plan on evaluating the effect of open label Asacol at a dose of 4.8 grams/day divided BID (twice per day) or TID (three times per day) on its ability to induce remission in patients with mild to moderately active ulcerative colitis. We hypothesize t...
What is the current status of trial NCT00194818?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2003-06. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00194818?
The interventions under investigation include: Asacol (mesalamine) (DRUG).
Who is sponsoring clinical trial NCT00194818?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00194818's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia